
June 1, 2023
RegMed Investors’ (RMi) pre-open: is the “deal” done or will there be more frothiness?
May 31, 2023
RegMed Investors’ (RMi) pre-open: the final trading session of May
May 30, 2023
RegMed Investors’ (RMi) pre-open: expect the expected
May 25, 2023
RegMed Investors’ (RMi) pre-open: what’s the plan?
May 24, 2023
RegMed Investors’ (RMi) pre-open: debt ceiling talks drag-on after breakdown
May 23, 2023
RegMed Investors’ (RMi) pre-open: what does one see or feel
May 22, 2023
RegMed Investors’ (RMi) pre-open: ominous doubts are growing; risk exposure needs to be examined
May 19, 2023
RegMed Investors’ (RMi) pre-open: who and what can be trusted re debt ceiling
May 18, 2023
RegMed Investors’ (RMi) pre-open: If you're buying into strength, you might be jumping onto a sinking ship
May 16, 2023
RegMed Investors’ (RMi) pre-open: are we owning the unownable?
May 15, 2023
RegMed Investors’ (RMi) pre-open: dangerous time to be invested in equities?
May 11, 2023
RegMed Investors’ (RMi) pre-open: curb any enthusiasm
May 10, 2023
RegMed Investors’ (RMi) pre-open: says who?
May 9, 2023
RegMed Investors’ (RMi) pre-open: Earnings are not the conclusion of anything
May 8, 2023
RegMed Investors’ (RMi) pre-open: I’d be watching and then selling
May 5, 2023
RegMed Investors’ (RMi) pre-open: downside risk remains
May 4, 2023
RegMed Investors’ (RMi) pre-open: sustainability
May 1, 2023
RegMed Investors’ (RMi) pre-open: share pricing trouble coming, just a matter of when?
April 28, 2023
RegMed Investors’ (RMi) pre-open: how now brown cow?
April 27, 2023
RegMed Investors’ (RMi) pre-open: plug-in and recharge the sector and show me some upside
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors